New ICD-10 PCS Codes in 2024

78 codes were added to the 2024 ICD-10-PCS code set, effective October 1, 2023.

02HW3RZ - Insertion of Short-term External Heart Assist System into Thoracic Aorta, Descending, Percutaneous Approach
02PW3RZ - Removal of Short-term External Heart Assist System from Thoracic Aorta, Descending, Percutaneous Approach
02WW3RZ - Revision of Short-term External Heart Assist System in Thoracic Aorta, Descending, Percutaneous Approach
0CSS0ZZ - Reposition Larynx, Open Approach
0CSS7ZZ - Reposition Larynx, Via Natural or Artificial Opening
0CSS8ZZ - Reposition Larynx, Via Natural or Artificial Opening Endoscopic
0DH17JZ - Insertion of Magnetic Lengthening Device into Upper Esophagus, Via Natural or Artificial Opening
0DH27JZ - Insertion of Magnetic Lengthening Device into Middle Esophagus, Via Natural or Artificial Opening
0DH37JZ - Insertion of Magnetic Lengthening Device into Lower Esophagus, Via Natural or Artificial Opening
0WHC0GZ - Insertion of Defibrillator Lead into Mediastinum, Open Approach
0WHC3GZ - Insertion of Defibrillator Lead into Mediastinum, Percutaneous Approach
0WHC4GZ - Insertion of Defibrillator Lead into Mediastinum, Percutaneous Endoscopic Approach
0WPC0GZ - Removal of Defibrillator Lead from Mediastinum, Open Approach
0WPC3GZ - Removal of Defibrillator Lead from Mediastinum, Percutaneous Approach
0WPC4GZ - Removal of Defibrillator Lead from Mediastinum, Percutaneous Endoscopic Approach
0WPCXGZ - Removal of Defibrillator Lead from Mediastinum, External Approach
0WWC0GZ - Revision of Defibrillator Lead in Mediastinum, Open Approach
0WWC3GZ - Revision of Defibrillator Lead in Mediastinum, Percutaneous Approach
0WWC4GZ - Revision of Defibrillator Lead in Mediastinum, Percutaneous Endoscopic Approach
0WWCXGZ - Revision of Defibrillator Lead in Mediastinum, External Approach
5A09B5K - Assistance with Respiratory Ventilation, Less than 8 Consecutive Hours, Intubated Prone Positioning
5A09C5K - Assistance with Respiratory Ventilation, 8-24 Consecutive Hours, Intubated Prone Positioning
5A09D5K - Assistance with Respiratory Ventilation, Greater than 24 Consecutive Hours, Intubated Prone Positioning
8E0U0EN - Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Open Approach
8E0U3EN - Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Percutaneous Approach
8E0U4EN - Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Percutaneous Endoscopic Approach
8E0U7EN - Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Via Natural or Artificial Opening
8E0U8EN - Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Via Natural or Artificial Opening Endoscopic
8E0W0EN - Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Open Approach
8E0W3EN - Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Percutaneous Approach
8E0W4EN - Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Percutaneous Endoscopic Approach
8E0W7EN - Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Via Natural or Artificial Opening
8E0W8EN - Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Via Natural or Artificial Opening Endoscopic
X051329 - Destruction of Renal Sympathetic Nerve(s) using Ultrasound Ablation, Percutaneous Approach, New Technology Group 9
X2H03R9 - Insertion of Intraluminal Device, Bioprosthetic Valve into Inferior Vena Cava, Percutaneous Approach, New Technology Group 9
X2H13R9 - Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9
X2H20R9 - Insertion of Intraluminal Device, Bioprosthetic Valve into Right Femoral Vein, Open Approach, New Technology Group 9
X2H30R9 - Insertion of Intraluminal Device, Bioprosthetic Valve into Left Femoral Vein, Open Approach, New Technology Group 9
X2H63V9 - Insertion of Dual-Chamber Intracardiac Pacemaker into Right Atrium, Percutaneous Approach, New Technology Group 9
X2HK3V9 - Insertion of Dual-Chamber Intracardiac Pacemaker into Right Ventricle, Percutaneous Approach, New Technology Group 9
X2HL0F9 - Insertion of Conduit to Short-term External Heart Assist System into Right Axillary Artery, Open Approach, New Technology Group 9
X2HM0F9 - Insertion of Conduit to Short-term External Heart Assist System into Left Axillary Artery, Open Approach, New Technology Group 9
X2HX0F9 - Insertion of Conduit to Short-term External Heart Assist System into Thoracic Aorta, Ascending, Open Approach, New Technology Group 9
X2KH3D9 - Bypass Right Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
X2KH3E9 - Bypass Right Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
X2KJ3D9 - Bypass Left Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
X2KJ3E9 - Bypass Left Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
X2U4079 - Supplement Coronary Artery/Arteries with Vein Graft Extraluminal Support Device(s), Open Approach, New Technology Group 9
X2UQ0P9 - Supplement Right Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9
X2UR0P9 - Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9
XNHG0F9 - Insertion of Tibial Extension with Motion Sensors into Right Tibia, Open Approach, New Technology Group 9
XNHH0F9 - Insertion of Tibial Extension with Motion Sensors into Left Tibia, Open Approach, New Technology Group 9
XNR80D9 - Replacement of Skull with Ultrasound Penetrable Synthetic Substitute, Open Approach, New Technology Group 9
XNRL099 - Replacement of Right Tarsal with Talar Prosthesis Synthetic Substitute, Open Approach, New Technology Group 9
XNRM099 - Replacement of Left Tarsal with Talar Prosthesis Synthetic Substitute, Open Approach, New Technology Group 9
XRGJ0B9 - Fusion of Right Ankle Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XRGK0B9 - Fusion of Left Ankle Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XRGL0B9 - Fusion of Right Tarsal Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XRGM0B9 - Fusion of Left Tarsal Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XW013L9 - Introduction of Elranatamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
XW013S9 - Introduction of Epcoritamab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
XW033K9 - Introduction of Sulbactam-Durlobactam into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW033P9 - Introduction of Glofitamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW033Q9 - Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW033R9 - Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW043K9 - Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9
XW043P9 - Introduction of Glofitamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 9
XW043Q9 - Introduction of Posoleucel into Central Vein, Percutaneous Approach, New Technology Group 9
XW043R9 - Introduction of Rezafungin into Central Vein, Percutaneous Approach, New Technology Group 9
XW053T9 - Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9
XW0DXJ9 - Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
XW0DXN9 - Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9
XW133H9 - Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW143H9 - Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
XX20X89 - Monitoring of Brain Electrical Activity, Computer-aided Detection and Notification, New Technology Group 9
XX2F3W9 - Monitoring of Musculoskeletal Muscle Compartment Pressure, Micro-Electro-Mechanical System, Percutaneous Approach, New Technology Group 9
XXE2X19 - Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9
XXE5XY9 - Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9